Clinical Trial Update: Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure [Phase 4]

View source ↗

Summary

The document reports the completion of a Phase 4 trial evaluating optimized dosing of lacosamide as add-on therapy for partial onset seizures. Results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial-onset Seizures

Drugs mentioned

• Vimpat (lacosamide)

Snippet

Sponsor: UCB Pharma | Conditions: Partial Epilepsies | Phase 4 | Status: COMPLETED | Results posted: 2013-01-24